Skip to main content
. Author manuscript; available in PMC: 2020 Dec 11.
Published in final edited form as: J Alzheimers Dis. 2020;78(3):927–937. doi: 10.3233/JAD-200625

Table 1:

Demographic and clinical characteristics of patients with LPA and PCA

Features LPA (N = 77) PCA (N = 59) FDR p-values
Gender (female) 46 (60%) 36 (61%) 0.88
Handedness (right) 68 (88%) 54 (92%) 0.68
Age Onset (years) 64 (57, 70) 58 (54, 63) 0.0002
Age MRI (years) 68 (61, 73) 62 (58.5, 69.5) 0.02
Education 16 (14, 16) 16 (13, 18) 0.66
Disease duration (years) 3.6 (2.7, 4.9) 4.7 (3.9, 6.8) 0.0004
Global PiB SUVR 2.4 (2.2, 2.6) 2.5 (2.3, 2.6) 0.29
BNT 9 (6.5, 12) 12 (9, 14) 0.02
BDAE repetition 6 (4, 8) 8 (6, 10) 0.02
NPI-Q 2 (1, 4) 3.5 (2, 6) 0.03
CDR sum of boxes 3 (1.5, 4.5) 4 (2, 7.5) 0.02
WMS-III VR% retention MOANS 8 (6, 10.5) 7.5 (4, 9.8) 0.29
AVLT long term recall MOANS 6 (4, 7) 6 (4, 8) 0.68
VOSP letters 19.5 (18, 20) 11.5 (5.25, 16) <0.0001
MOCA 16 (10, 19) 18 (10, 20) 0.62
MSD-UPDRS III 3 (1.375, 6) 2 (0, 8) 0.29
Rey-O MOANS 6 (2, 9.25) 2 (2, 2) 0.0002

Data are shown as Q1 (Q1, Q3) or N (%). Significant adjusted p-values are bolded. AVLT: Auditory Verbal Learning Test, Rey-O-MOANS: Rey Osterrieth Mayo Older American Normative Scale, MOCA: Montreal Cognitive Assessment Battery; CDR: Clinical Dementia Rating, VOSP: visual object and space perception, WMS-III VR% retention MOANS: Wechsler Memory Scale III Visual Reproduction MOANS, BNT: Boston Naming Test, BDAE: Boston Diagnostic Aphasia Examination, NPI-Q: Neuropsychiatric Inventory Brief Questionnaire, MSD-UPDRS III: Movement Disorder Society Unified Parkinson’s Disease Rating Scale Part III.